Irreversible electroporation to create tissue scaffolds

• US 9,598,691 B2
• Filed: 04/29/2009
• Issued: 03/21/2017
• Est. Priority Date: 04/29/2008
• Status: Active Grant

• Current Assignee: Virginia Tech Intellectual Properties, Inc.
• Original Assignee: Virginia Tech Intellectual Properties, Inc.
• Inventors: Davalos, Rafael V.
• Primary Examiner(s): Kim, Taeyoon
• Application Number:
  US12/432,295
• Publication Number:
  US 20090269317A1
• Time in Patent Office: 2,883 Days
• US Class Current: 1/1
• CPC Class Codes: A61K 35/12 Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells vaccines or medicinal preparations containing antigens or antibodies A61K39/00
• CPC Class Codes: A61L 2430/28 for liver reconstruction
• CPC Class Codes: A61L 2430/40 Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
• CPC Class Codes: A61L 27/3604 characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
• CPC Class Codes: A61L 27/3625 Vascular tissue, e.g. heart valves
• CPC Class Codes: A61L 27/3633 Extracellular matrix [ECM]
• CPC Class Codes: A61L 27/3691 characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
• CPC Class Codes: A61L 27/38 containing added animal cells organs or tissue containing native cells A61L27/36
• CPC Class Codes: C12N 13/00 Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
• CPC Class Codes: C12N 2533/90 Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
• CPC Class Codes: C12N 5/0068 General culture methods using substrates for specific animal cell type C12N5/06

Abstract

The present invention provides engineered tissue scaffolds, engineered tissues, and methods of using them. The scaffolds and tissues are derived from natural tissues and are created using non-thermal irreversible electroporation (IRE). Use of IRE allows for ablation of cells of the tissue to be treated, but allows vascular and neural structures to remain essentially unharmed. Use of IRE thus permits preparation of thick tissue scaffolds and tissues due to the presence of vasculature within the scaffolds. The engineered tissues can be used in methods of treating subjects, such as those in need of tissue replacement or augmentation.

Claims

1. A method of making an engineered tissue by electrical ablation comprising:

positioning at least one electrode in a target region containing tissue cells;

applying a plurality of electrical pulses through the electrode in an amount sufficient to induce cell death by electrical ablation of the tissue cells in the target region in vivo to create an engineered tissue scaffold, wherein the step of applying leaves intact vascular structures present in the target region; and

seeding the ablated target region in vivo or in vitro and allowing seeded cells to proliferate to create the engineered tissue.

2. The method of claim 1, further comprising removing cellular debris from the ablated target region by one or more of physical, chemical and enzymatic techniques.

3. The method of claim 2, wherein the step of removing includes introducing a detergent material to the engineered tissue scaffold after the applying step.

4. The method of claim 2, wherein the step of removing includes pumping a material to the engineered tissue scaffold using a perfusion pump.

5. The method of claim 4, wherein the step of pumping a material includes pumping a detergent material to the engineered tissue scaffold.

6. The method of claim 1, where the step of seeding includes seeding the ablated target region, in vitro, the method further comprising exposing the seeded scaffold to conditions that permit growth of the seeded cells.

7. The method of claim 6, wherein the step of exposing includes incubating the seeded target region in an incubator at a predetermined temperature.

8. The method of claim 6, wherein:

the step of applying includes applying the electrical pulses to the target region of an animal, in vivo; and

the step of seeding includes seeding the ablated target region with cells from a human.

9. The method of claim 8, wherein the electrical ablation is used on the target region of an animal, or of a human, and the target region seeded with cells is removed from the animal for implantation of the target region into a human.

10. The method of claim 1, further comprising implanting the engineered tissue into a subject in need of tissue replacement, the engineered tissue replacing at least a portion of an organ that has diminished or no function wherein the organ is a heart, a lung, a liver, a kidney, a urinary bladder, a brain, an ear, an eye, or skin.

11. The method of claim 1, wherein the step of applying includes applying the electrical pulses in a manner not to cause irreversible damage to major blood vessels present in the target region.

12. The method of claim 1, further comprising attaching the target region to a bioreactor perfusion system in vitro.

13. The method of claim 12, wherein the step of attaching is performed prior to the step of seeding.

14. The method of claim 12, after the step of attaching, further comprising perfusing the target region with nutrients.

15. The method of claim 14, wherein the step of perfusing occurs after the step of seeding.

16. The method of claim 14, after the step of attaching, further comprising perfusing the target region with saline.

17. The method of claim 12, after the step of applying the electrical pulses, further comprising perfusing the target region with detergent.

18. A method of making an engineered tissue by irreversible electroporation comprising:

positioning at least one electrode in a target region containing tissue cells;

applying a plurality of electrical pulses through the electrode in an amount sufficient to induce cell death by irreversible electroporation of the tissue cells in the target region in vivo, to create an engineered tissue scaffold;

wherein the step of applying leaves intact vascular structures present in the target region; and

seeding the engineered tissue scaffold in vivo or in vitro and allowing seeded cells to proliferate to create the engineered tissue.

19. The method of claim 18, wherein:

the step of applying includes applying the electrical pulses to the target region, in vivo; and

the step of seeding includes seeding the ablated target region, in vivo.

20. The method of claim 18, wherein:

the step of applying includes applying the electrical pulses to the target region, in vivo; and

the step of seeding includes seeding the ablated target region, in vitro.

21. The method of claim 18, further comprising removing cellular debris from the ablated target region by introducing a detergent material to the engineered tissue scaffold.

22. The method of claim 18, where the step of seeding includes seeding the ablated target region, in vitro, the method further comprising incubating the seeded target region in an incubator at a predetermined temperature to permit growth of the seeded cells in the tissue scaffold.

23. The method of claim 18, further comprising implanting the engineered tissue into a subject in need of tissue replacement, the engineered tissue replacing at least a portion of an organ that has diminished or no function wherein the organ is a heart, a lung, a liver, a kidney, a urinary bladder, a brain, an ear, an eye, or skin.

24. The method of claim 18, further comprising attaching the target region to a bioreactor perfusion system in vitro.

25. The method of claim 24, after the step of attaching, further comprising perfusing the target region with nutrients.

26. The method of claim 24, after the step of applying the electrical pulses, further comprising perfusing the target region with detergent.

27. A method of making an engineered tissue scaffold by electrical ablation comprising:

positioning at least one electrode in a target region containing tissue cells;

applying a plurality of electrical pulses through the electrode in an amount sufficient to induce cell death by electrical ablation of the tissue cells in the target region;

wherein the step of applying leaves intact vascular structures present in the target region in vivo; and

removing the ablated tissue region from a body.

28. The method of claim 27, further comprising seeding the ablated tissue region with cells.

29. The method of claim 28, wherein the step of seeding includes seeding the ablated tissue region in vitro.

30. The method of claim 27, further comprising implanting the engineered tissue scaffold into a subject in need of tissue replacement, the engineered tissue scaffold replacing at least a portion of an organ that has diminished or no function wherein the organ is a heart, a lung, a liver, a kidney, a urinary bladder, a brain, an ear, an eye, or skin.

31. The method of claim 27, further comprising removing cellular debris from the ablated target region by introducing a detergent material in vitro.

32. The method of claim 27, further comprising attaching the target region to a bioreactor perfusion system in vitro.

33. The method of claim 32, after the step of attaching, further comprising perfusing the target region with nutrients.

34. The method of claim 32, after the step of applying the electrical pulses, further comprising perfusing the target region with a detergent.

40. The method of claim 27, wherein the engineered tissue scaffold has a thickness that approaches or mimics the thickness of the type of tissue or organ from which the engineered tissue scaffold is derived.

41. The method of claim 27, wherein the engineered tissue scaffold has a thickness of about 5 mm or more.

35. A method of making an engineered tissue by electrical ablation comprising:

positioning at least one electrode in a target region containing tissue cells;

applying, in vivo, a plurality of electrical pulses through the electrode in an amount sufficient to induce cell death by electrical ablation of the tissue cells in the target region to create an engineered tissue scaffold, wherein the step of applying is based on a protocol that leaves intact vascular structures for microcirculation in the target region;

seeding the ablated target region and allowing seeded cells to proliferate to create the engineered tissue.

36. The method of claim 35, further comprising removing the ablated target region from a body to create the engineered tissue scaffold.

37. The method of claim 35, wherein the vascular structures for microcirculation are left intact by limiting an amount of current delivered to the target region to a maximum of 5 amps.

38. The method of claim 35, wherein the vascular structures for microcirculation are left intact by limiting a voltage gradient delivered to the target region to 10 to 10,000 V/cm.

39. The method of claim 35, wherein the vascular structures for microcirculation are left intact by limiting a charge delivered to the target region to 22.5 mC.